TCL Archive In Brief: Three Centers Win Comprehensive Designation; Hiatt Named Deputy Director, NCI Cancer Control October 31, 1997
TCL Archive Abraxane-Gemcitabine Combination Extends Overall Survival in Phase III Trial January 31, 2014